Company Overview and News
KUALA LUMPUR (Aug 7): The FBM KLCI rose 0.39% at mid-morning today, lifted by index-linked blue chips and tracking the steady regional markets.
7052 7036 5681 BATS 4162 3034 1481 5014 6033 0152 1783 PNADF 5225 SGPBY 5209 2216 2739 MYPRY Q0F IHHHF PNAGF
KUALA LUMPUR (Aug 7): Shares in Advance Synergy Bhd jumped 6.25% in active trade this morning after the company said it is selling its indirect stake in 40%-owned associate Helenium Holdings Ltd, which owns a freehold mixed-use property in Kilburn High Road, London, for £8.73 million (RM46.637 million).
KUALA LUMPUR (Aug 7): The FBM KLCI is seen trending sideways today with immediate support at 1,764, despite the firmer overnight close at most global markets, as buying support at the local bourse is likely to be lukewarm.
0177 5106 5260 7168 1481 9466
KUALA LUMPUR (Aug 6): Based on corporate announcements and news flow today, stocks in focus for Tuesday (Aug 7) may include the following: Sime Darby Plantation Bhd, PRG Holdings Bhd, Pasukhas Group Bhd, KKB Engineering Bhd, SKH Consortium Bhd, Axis Real Estate Investment Trust, Only World Group Holdings Bhd, MCT Bhd and Advance Synergy Bhd.
0177 5106 5260 7168 BSMAF 1481 9466 1818
KUALA LUMPUR (Aug 6): Advance Synergy Bhd is disposing of its indirect stake in 40%-owned associate Helenium Holdings Ltd, which owns a freehold mixed-use property in Kilburn High Road, London, for £8.73 million (RM46.637 million).
BSMAF 1481 1818
KUALA LUMPUR (July 2): The FBM KLCI fell 0.47% at midday break today, as latest data showed business conditions across Malaysia’s manufacturing sector deteriorating, albeit at a slower pace in June.
HLFBF PBLOF 7113 7036 TPGVF 1295 7077 9334 DKSHY 5347 3301 8613 TNABY 5908 HRGHY SPMXF 1082 5681 5168 1481 TGLVY 5139 4588 SPMXY 0900 5819 TNABF DKSHF
KUALA LUMPUR (July 2): The FBM KLCI remained subdued at mid-morning today after data showed business conditions across Malaysia’s manufacturing sector deteriorating albeit at a slower pace in June.
7052 PBLOF BATS 4162 1295 3794 2089 7077 5199 DKSHY KLKBY 3867 7206 HIPEF 5908 SPMXF UPBMF 8133 1481 5139 2445 4588 SPMXY 0026 0900 5819 DKSHF
KUALA LUMPUR (June 29): The FBM KLCI briefly crossed the 1,700-point level in the morning session today before paring some gains to close 1.8% higher at the break.
7251 MLYNF 7113 TPGVF 2089 5255 KLKBY 1023 5347 TNABY 2836 1929 HRGHY MLYBY UPBMF 5168 1481 CIMDF TGLVY 5139 1155 5216 2445 0900 TNABF
KUALA LUMPUR (June 29): The FBM KLCI rose 1.38% at mid-morning today on 1H18 window-dressing activities, led by gains in Tenaga Nasional Bhd.
7172 7251 SPMXF 8621 7113 TPGVF 7765 5168 1481 5255 TGLVY 5139 KLKBY 2445 5216 SPMXY 5347 3026 0900 TNABY TNABF 1929 HRGHY
At 9.02am, the benchmark FTSE Bursa Malaysia KLCI (FBM KLCI) stood at 1,843.48, declining 1.79 points from 1,845.27 at yesterday's close. — Picture by Azneal IshakKUALA LUMPUR, March 16 ― Shares on Bursa Malaysia opened lower this morning on the back of Wall Street’s meagre performance, coupled with global market participants' reluctance amid a trade uncertainty environment, dealers said.
BSMAF 1481 1818
KUALA LUMPUR, March 15 — Bursa Malaysia closed at an intra-day low today on nervousness over the direction of US economic and foreign policies, leaving the local bourse in the red throughout the day, dealers said.
PBLOF 5225 Q0F 1295 BSMAF 1481 5025 IHHHF 1818
2018-08-13 - Asif
Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...
2018-08-13 - Asif
Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...
2018-08-13 - Asif
Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...